Amneal Pharmaceuticals Inc AMRX:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:01 PM EST
2.61UNCH (UNCH)
Volume
6,821
Close
2.61quote price arrow up+0.19 (+7.85%)
Volume
1,314,265
52 week range
1.95 - 5.13
Loading...
  • Open2.43
  • Day High2.65
  • Day Low2.41
  • Prev Close2.42
  • 52 Week High5.13
  • 52 Week High Date12/23/21
  • 52 Week Low1.95
  • 52 Week Low Date10/14/22

Key Stats

  • Market Cap792.377M
  • Shares Out303.59M
  • 10 Day Average Volume0.59M
  • Dividend-
  • Dividend Yield-
  • Beta1.28
  • YTD % Change-45.51

KEY STATS

  • Open2.43
  • Day High2.65
  • Day Low2.41
  • Prev Close2.42
  • 52 Week High5.13
  • 52 Week High Date12/23/21
  • 52 Week Low1.95
  • 52 Week Low Date10/14/22
  • Market Cap792.377M
  • Shares Out303.59M
  • 10 Day Average Volume0.59M
  • Dividend-
  • Dividend Yield-
  • Beta1.28
  • YTD % Change-45.51

RATIOS/PROFITABILITY

  • EPS (TTM)-0.87
  • P/E (TTM)-3.00
  • Fwd P/E (NTM)3.65
  • EBITDA (TTM)403.345M
  • ROE (TTM)-40.75%
  • Revenue (TTM)2.139B
  • Gross Margin (TTM)35.69%
  • Net Margin (TTM)-12.59%
  • Debt To Equity (MRQ)941.71%

EVENTS

  • Earnings Date02/28/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Amneal Pharmaceuticals Inc

 

Profile

MORE
Amneal Pharmaceuticals, Inc. is a pharmaceutical company. The Company specializes in developing, manufacturing, marketing and distributing generic and branded specialty pharmaceutical products. It operates through three segments: Generics, Specialty, and AvKARE. Its Generics segment includes approximately 250 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables...
Paul Meister
Independent Chairman of the Board
Chirag Patel
President, Co-Chief Executive Officer, Co-Founder, Director
Anastasios Konidaris
Chief Financial Officer, Executive Vice President
Andrew Boyer
Executive Vice President, Chief Commercial Officer - Generics
Gustavo Pesquin
Executive Vice President, Chief Commercial Officer - Speciality
Address
400 Crossing Blvd Fl 3
Bridgewater, NJ
08807-2863
United States

Top Peers

SYMBOLLASTCHG%CHG
ENDPQ
Endo International PLC
0.095-0.0031-3.16%
EBS
Emergent BioSolutions Inc
11.77+0.16+1.38%
PAHC
Phibro Animal Health Corp
12.05+0.07+0.58%
PROC
Procaps Group SA
6.44-0.18-2.72%
COLL
Collegium Pharmaceutical Inc
21.25-0.20-0.93%